AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.110
-0.060 (-5.13%)
Mar 13, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Employees
AEON Biopharma had 5 employees as of December 31, 2024. The number of employees decreased by 5 or -50.00% compared to the previous year.
Employees
5
Change
-5
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$600
Market Cap
15.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Jun 30, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Jun 30, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 8 | - | - |
| Sep 30, 2022 | 9 | 3 | 50.00% |
| Jun 30, 2021 | 6 | - | - |
| Mar 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IGC Pharma | 70 |
| Lantern Pharma | 24 |
| Tempest Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Hyperion DeFi | 14 |
| Tiziana Life Sciences | 9 |
AEON News
- 7 weeks ago - AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - GlobeNewsWire
- 3 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - GlobeNewsWire
- 4 months ago - AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes - GlobeNewsWire
- 5 months ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
- 7 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire